Blume Ventures provides pre-series A and early stage funding to tech-focused/tech-enabled ventures. They are typically the first institutional investors in their portfolio companies and invest for about 8-10 years. They are proponents of a collaborative approach and like to co-invest with like-minded angels and seed funds. They then provide follow-on investments to their stellar portfolio companies.

Blume Ventures

Leo Capital is a venture capital fund investing in early-stage and technology-centric opportunities. The venture capital fund was founded in 2018 and is based in New Delhi, India.

Leo Capital

Orios Venture Partners is an early stage venture fund which primarily invests in software and technology enabled startups.

Orios Venture Partners

W Health Ventures invests in digital health companies that are transforming healthcare delivery. It designs, builds, and grows healthcare companies that address critical unmet healthcare needs and simplify the experience for patients and providers. WHV focuses on highly scalable and impactful ideas that leverage the power of AI and technology. The firm was founded in 2020 and is based in Boston, Massachusetts.

W Health Ventures

Merisis Advisors is leading financial management company providing diverse services in Investment banking, Technology Deals, Mergers.

Merisis Advisors

PharmEasy is a health tech startup offering services such as teleconsultation, medicine deliveries, and diagnostic test sample collections. It also operates an online pharmacy that helps patients connect with local pharmacy stores and diagnostic centers in order to fulfill their extensive medical needs. The startup company is funded and backed by Caisse de Dépôt et Placement du Québec (CDPQ), Ascent Health, Bessemer Venture Partners, Orios Venture Partners, Eight Roads Ventures, InnoVen Capital, and Temasek Holdings. PharmEasy was founded in 2015 by Dharmil Sheth, Mikhil Innani, and Dhaval Shah as a subsidiary of Ascent Health.

PharmEasy

Lightrock is a global growth capital platform that backs purpose-driven entrepreneurs tackling the world’s biggest challenges. Lightrock invests in companies that pursue scalable and tech-driven business models around the key impact themes of people, planet, and productivity/tech for good. Lightrock’s portfolio includes more than 90 high-growth companies across Europe, US, Latin America, India and Africa, supported by more than 100 Lightrock professionals based in 6 global offices. Lightrock is backed by LGT, the international private banking and asset management group, and other leading global institutions. For more information, please visit www.lightrock.com.

Lightrock

HealthQuad’s investment philosophy is to create value by empowering visionary entrepreneurs building unique solutions that have the potential to redefine the way the society prevents and treats illness. Their approach is defined by “inspired ownership” and they strive to act as a meaningful strategic partner and not just as a financial sponsor. They provide a platform where entrepreneurs can work with us to get not only the capital but also the advice, support, and tools they need to achieve their market potential. In the eyes of the entrepreneurs, they see that the breadth and depth of their expertise, their strong network and their rich ecosystem, are their raison d’être for partnering with us.

HealthQuad

Alteria Capital is a type of risk capital that complements and Venture capital was used to co-invest. It is less expensive than equity and is beneficial. Increase the rewards on stock ownership. Alteria Capital is a venture debt fund that focuses on innovative firms with significant VC backing.

Alteria Capital

World Within Ventures invests in and builds companies with breakthrough technologies across life sciences, food, and infrastructure.

World Within Ventures

Flipkart Ventures is the venture arm of Flipkart.

Flipkart Ventures

BeatO

BeatO is a developer of a health monitoring application that helps diabetic patients to track their glucose levels. The company's application provides a full-stack diabetes management program that helps the user manage exercising, diet, medicine intake, and diagnosis, and connects the users with doctors and diabetes educators for instant real-time guidance. Founded in 2015 by Gautam Chopra, Yash Sehgal, Kunal Kinalekar, and Abhishek Kumar, BeatO is headquartered in New Delhi, Delhi.

eatO is an Indian diabetes care platform that offers real-time patient monitoring via IoT-connected devices that provide customized insights on a mobile app. The company’s ecosystem includes doctors, coaches and nutritionists. The platform ensures proactive management of chronic conditions. Furthermore, it claims to reduce three-month average sugar levels (HbA1c) by 2.16%.

Membership-based, non-insurance healthcare companies helping maintain a steady state of well being.

Preventive Healthcare

Policy Ensure Partners with BeatO to Spread Diabetes Awareness and Insurance Access in India

eatO is an Indian diabetes care platform that offers real-time patient monitoring via IoT-connected devices that provide customized insights on a mobile app. The company’s ecosystem includes doctors, coaches and nutritionists. The platform ensures proactive management of chronic conditions. Furthermore, it claims to reduce three-month average sugar levels (HbA1c) by 2.16%. The company has served more than 3 million diabetes users as of May 2024. BeatO has expanded its operations outside India to countries in Southeast Asia, Middle East, as well as the US.Funding and financialsIn November 2022, the company raised USD 33 million via a Series B funding round led by Lightrock India. The funds were used toward product expansion.&nbsp;

eatO is an Indian diabetes care platform that offers real-time patient monitoring via IoT-connected devices that provide customized insights on a mobile app. The company’s ecosystem includes doctors, coaches and nutritionists. The platform ensures proactive management of chronic conditions. Furthermore, it claims to reduce three-month average sugar levels (HbA1c) by 2.16%.The company has served more than 3 million diabetes users as of May 2024. BeatO has expanded its operations outside India to countries in Southeast Asia, Middle East, as well as the US.Funding and financialsIn November 2022, the company raised USD 33 million via a Series B funding round led by Lightrock India. The funds were used toward product expansion.

Cardiomo Care is developing noninvasive wearable devices to alert users and caretakers when there are abnormalities in the heartbeat. The company’s AI engine, trained on existing and growing data sets, can predict potential heart issues up to two hours before they occur, enabling early detection and intervention for arrhythmias and other cardiovascular diseases (CVDs).The company's product, CardiomoPatch, is a waterproof, wearable patch capable of long-term wear with a 10-day battery life. The patch monitors a patient's cardiac data, including ECG outputs, breathing, and skin temperature, and transmits the data via a mobile app for analysis by Cardiomo's AI engine.&nbsp;As of May 2024, the company is yet to commercialize its product and has over 1,600 pre-orders.

Cardiomo Care

Omada is a prevention-focused digital therapeutics startup that helps members achieve health goals through lifestyle changes. It offers four evidence-based, virtual prevention programs for managing hypertension, musculoskeletal (MSK) issues, prediabetes, and diabetes.Omada offers real-time data tracking through connected devices (such as wireless scales, blood pressure, and glucose monitors) and access to personalized coaching sessions via a mobile app as part of its prevention program. It also provides an online community of peers with similar health conditions to discuss challenges and provide support. In May 2021, Omada became the first fully-virtual healthcare provider to earn the National Committee for Quality Assurance’s Population Health Program Accreditation for its type 2 diabetes and type 2 diabetes + hypertension programs.Unlike its peers, Omada operates a performance-based business model where it charges clients an enrollment fee based on the number of users and a performance fee based on how much weight their employees lose. In May 2020, the company acquired virtual physical therapy startup Physera.Key customers and partnershipsAs of May 2024, Omada had more than 1 million members from more than 1,900 enterprise clients across all 50 US states. Its B2B employer and health plan client base include key clients such as American Eagle, Kaiser Permanente, Costco Wholesale, 3M, and Marvin. Additionally, the company has partnered with health systems and hospitals such as Intermountain Healthcare to provide its preventive programs as a covered benefit.In <a href="https://sp-edge.com/updates/15587">January 2023</a>, the company partnered with health service company Castell (a subsidiary of Intermountain Healthcare) to provide its diabetes programs to members from Intermountain Healthcare’s primary care providers in its Utah Medical Group. Further in <a href="https://sp-edge.com/updates/25245">January 2024</a>, the company partnered with Amazon to expand access to its cardiometabolic program.

Omada Health

VillageMD provides primary care services for patients. It also provides tools, technology, and staffing support needed for physicians to deliver high-quality services. VillageMD’s service delivery methods include traditional freestanding clinics, Village Medical at Walgreens co-located clinics, as well as at-home and around-the-clock virtual visits. It also leverages a team-based approach to care where physicians lead nurse practitioners, pharmacists, mental health specialists, and dietitians to offer a holistic care program. The technology of VillageMD includes docOS, an operating system that enables better patient care by connecting various clinical source systems with ongoing patient-generated data coupled with an AI engine to continuously analyze messages to enable patient self-care.The company made several acquisitions to expand its footprint: 1) <a href="https://sp-edge.com/updates/14347">Summit Health</a> for USD 8.9 billion in November 2022, 2) Healthy Interactions, an interactive patient education platform, in February 2022, and 3) <a href="https://sp-edge.com/updates/16968">Starling Physicians</a>, a primary care and specialty care provider, in March 2023.Key customers and partnershipsIn June 2020, VillageMD and Walgreens Boots Alliance announced a collaborative effort to open at least 600 Village Medical centers at Walgreens across more than 30 US markets by 2025. Walgreens invested USD 5.2 billion in VillageMD (from the previously announced USD 1.0 billion), raising its ownership stake to 63% (from 30%).However, as of May 2024, Walgreens had plans to close 160 VillageMD clinics as part of a cost-cutting plan.

VillageMD

Cityblock Health is a value-based healthcare provider focused on delivering comprehensive care to underserved communities, primarily Medicaid and lower-income Medicare beneficiaries. The company combines primary care, behavioral health, and social services to address the complex physical, mental, and social needs of its members.Cityblock's model involves partnering with local community-based organizations and deploying multidisciplinary care teams that include doctors, nurses, behavioral health specialists, and community health workers. These teams provide personalized care through 24/7 access to multi-modal care delivery, including in-home visits, telehealth, and community health hubs.The services of Cityblock are available to members at no additional cost if they are covered by an eligible health plan.Key Customers and PartnershipsAs of May 2024, the company’s services were available in seven states across the US and served over 100,000 members.In May 2024, it partnered with <a href="https://sp-edge.com/updates/29647">Sunshine Health</a> to expand to Florida, and, in <a href="https://sp-edge.com/updates/13270">September 2022</a>, it partnered with MDwise to expand into Indiana. Prior to that, the company had partnered with insurance providers such as ConnectiCare (Connecticut), Tufts Health Plan (Massachusetts), Emblem Health (New York), Healthy Blue (North Carolina), Molina Healthcare (Ohio) and CareFirst (Washington DC).Funding and FinancialsCityblock is a spin-off of Sidewalk Labs, an Alphabet company that incubates and invests in tech companies and products to improve urban infrastructure. It completed a USD 400 million Series D funding round led by Softbank in <a href="https://sp-edge.com/updates/5326">September 2021</a>, valuing the company at USD 5.7 billion. The funds were used to expand its services.

Cityblock Health

Everside Health (formerly Paladina Health) offers preventative care for chronic conditions and primary, mental and occupational healthcare treatments for acute conditions. Patients benefit from around-the-clock access to care, same-day or next-day appointments for in-person, and virtual care visits with zero copays.Everside aims to generate around 17% healthcare cost savings in three years and 31% in five years for its corporate members by leveraging a data-driven approach to care coordination.The company leverages data from past medical records, predictive analytics, and AI in the delivery of preventative care services.Founded in 2010 under the name Paladina Health, the company was rebranded in November 2020 as Everside Health following a merger between three primary care groups (Paladina, Activate Healthcare, and Healthstat). Furthermore, in February 2024, Everside Health merged with primary care provider Marathon Health to form a combined entity that would operate as Marathon Health, and, as of May 2024, the integration was ongoing.Key customers and partnershipPost-merger with Marathon Health, the combined entity would serve 2.5 million patients through over 680 clinics across 41 states.Funding and financialsThe company received its most recent investment in July 2022, amounting to USD 164 million in growth equity funding. The round was led by New Enterprise Associates (NEA). The funds were allocated toward growing its market presence and exploring opportunities for M&amp;A as well as to enhance and improve its product features. Additionally, the firm planned to expand its coverage of specialty care services aimed at individuals, employers, and union organizations.

Everside Health

Platforms offer a subscription-based or B2B-sponsored, evidence-based program for managing a specific long-term health condition.

DPCs offer value-based primary and preventive care services addressing whole-person (social, mental, physical) needs for a fixed monthly or annual fee paid by either the patient, insurance provider, or employer.

Companies offer B2B and D2C evidence-based treatments delivered via software programs to prevent and manage a variety of chronic conditions.

Tools that collect and analyze real-time patient data that supports healthcare providers with clinical decisions,  improves patient outcomes, and reduces medical errors.

Companies offer independent physician practices and hospitals with the tools (patient engagement, care coordination, administrative services) to help manage and improve clinical health outcomes of a defined group of individuals or large populations.

Platforms are used to track and gather patient health-related information via either a connected device or at-home test kits to detect the early onset of disease and identify any abnormalities in readings—but do not include a treatment plan.

To gather large amounts of real-time data for chronic care management, DTx, and patient monitoring

XR used by some startups for chronic pain management

Offers digital means of providing direct primary care, passive remote monitoring, chronic care management, etc.

AI/ML is used in predictive analytics, diagnostics tools, and population management

Offers tailored preventive interventions and treatments to the specific needs and characteristics of each individual

BeatO

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless